Dr. Taddei is Chief of Gastroenterology at VA Connecticut Healthcare System and Professor of Medicine (Digestive Diseases) and Vice Chief of Faculty Development (Digestive Diseases) at Yale School of Medicine. Her clinical interests focus on developing systems and programs to deliver outstanding multidisciplinary care to people with liver cancer. She directs the Liver Cancer Program at VA Connecticut Healthcare System and founded a VA regional tumor board serving Connecticut, Massachusetts, Rhode Island, and Vermont. Her research focuses on outcomes and clinical trials in cirrhosis and liver cancer. She is co-principal investigator of the Veterans Outcomes and Costs Associated with Liver disease (VOCAL) study group, the Statins and Cirrhosis - Reducing Events of Decompensation (SACRED) clinical trial, and the PREventing Liver Cancer Mortality through Imaging with Ultrasound vs. MRI (PREMIUM) clinical trial. Passionate about educating, mentoring and sponsoring the next generation, Dr. Taddei has been recognized with teaching awards for her dedication to the education and career advancement of medical students, residents, and fellows.
|Alvan R. Feinstein Award||Yale School of Medicine||2017|
|Digestive Diseases Fellowship Teaching Award||Yale University School of Medicine, Section of Digestive Diseases||2011|
|Best Teacher – YNHH Hospitalist Service||Yale-New Haven Hospital||2010|
|Samuel Kushlan Award for Clinical Excellence in Fellowship||Yale University||2007|